
Articles
-
5 days ago |
healio.com | Brandon D. Ayres |Anthony DeFino |Nancy Hemphill
KIAWAH ISLAND, S.C. — Povicaine, launched in late 2024, has “become a staple in our practice,” Brandon D. Ayres, MD, said in this Healio Video Perspective from Kiawah Eye. Ayres, who practices in the greater Philadelphia area at Wills Eye Hospital and Ophthalmic Partners, uses Povicaine (povidone-iodine 1.25% and proparacaine 0.5%, ImprimisRx) in procedures such as collagen cross-linking, superficial keratectomy, lamellar keratectomy and suture removal.
-
1 week ago |
healio.com | Nancy Hemphill
Key takeaways: A study compared the optical and refractive performance of an enhanced monofocal IOL vs. an aberration-free monofocal IOL. Uncorrected distance visual acuity was better with the EM IOL than with the AFM IOL. KIAWAH ISLAND, S.C. — Eyes implanted with a novel enhanced monofocal IOL achieved usable intermediate and near visual acuity while maintaining distance vision, according to Christine Hill, MD, at Kiawah Eye.
-
3 weeks ago |
healio.com | Brandon D. Ayres |Nancy Hemphill |Anthony DeFino
Read more LOS ANGELES — In this Healio Video Perspective from the ASCRS meeting, Brandon D. Ayres, MD, discusses the effectiveness and safety of a 27-gauge needle-tipped vitrector for pars plana anterior vitrectomy. In 27 cases, vitreous was “adequately cleared” from the anterior chamber. The complication rate was low, Ayres said, with surgeons reporting satisfaction with the vitrector.
-
1 month ago |
healio.com | Nancy Hemphill
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
-
1 month ago |
healio.com | Nancy Hemphill
Key takeaways: Ophthalmology has large patient numbers and market opportunities. Investors look for differentiated products or technologies with strong competitive positioning. LOS ANGELES — Today’s volatile environment is impacting the markets, but innovation in ophthalmology will drive the sector and lead to increased value, a JP Morgan managing director told attendees at SightLine.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →